“Virtual” (Computed) Fractional Flow Reserve Current Challenges and Limitations by Morris, Paul D. et al.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S VO L . 8 , N O . 8 , 2 0 1 5
ª 2 0 1 5 B Y T H E AM E R I C A N C O L L E G E O F C A R D I O L O G Y F O U N DA T I O N I S S N 1 9 3 6 - 8 7 9 8 / $ 3 6 . 0 0
P U B L I S H E D B Y E L S E V I E R I N C . h t t p : / / d x . d o i . o r g / 1 0 . 1 0 1 6 / j . j c i n . 2 0 1 5 . 0 4 . 0 0 6VIEWPOINT
INTERVENTIONAL ISSUES“Virtual” (Computed)
Fractional Flow Reserve
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MaFractional ﬂow reserve (FFR) is the “gold standard” for assessing the physiological signiﬁcance of coronary artery
disease during invasive coronary angiography. FFR-guided percutaneous coronary intervention improves patient
outcomes and reduces stent insertion and cost; yet, due to several practical and operator related factors, it is used
in <10% of percutaneous coronary intervention procedures. Virtual fractional ﬂow reserve (vFFR) is computed using
coronary imaging and computational ﬂuid dynamics modeling. vFFR has emerged as an attractive alternative to
invasive FFR by delivering physiological assessment without the factors that limit the invasive technique. vFFR may
offer further diagnostic and planning beneﬁts, including virtual pullback and virtual stenting facilities. However, there
are key challenges that need to be overcome before vFFR can be translated into routine clinical practice. These span
a spectrum of scientiﬁc, logistic, commercial, and political areas. The method used to generate 3-dimensional
geometric arterial models (segmentation) and selection of appropriate, patient-speciﬁc boundary conditions represent
the primary scientiﬁc limitations. Many conﬂicting priorities and design features must be carefully considered for
vFFR models to be sufﬁciently accurate, fast, and intuitive for physicians to use. Consistency is needed in how
accuracy is deﬁned and reported. Furthermore, appropriate regulatory and industry standards need to be in
place, and cohesive approaches to intellectual property management, reimbursement, and clinician training are
required. Assuming successful development continues in these key areas, vFFR is likely to become a desirable
tool in the functional assessment of coronary artery disease. (J Am Coll Cardiol Intv 2015;8:1009–17)
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ABBR EV I A T I ON S
AND ACRONYMS
CAG = invasive coronary
angiography
CFD = computational ﬂuid
dynamics
CTCA = computed
tomographic coronary
angiography
FDA = U.S. Food and Drug
Administration
FFR = fractional ﬂow reserve
PCI = percutaneous coronary
intervention
QCA = quantitative coronary
angiography
vFAI = virtual functional
assessment index
vFFR = virtual fractional ﬂow
reserve
3D = 3-dimensional
Morris et al. J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 8 , 2 0 1 5
”Virtual” (Computed) FFR J U L Y 2 0 1 5 : 1 0 0 9 – 1 7
1010own visual assessment is physiologically ac-
curate, allied to a misconception that multi-
ple visual assessments (e.g., in a “Heart
Team” setting) or a prior noninvasive test
of ischemia improve their accuracy. Finally,
despite the FAME (Fractional Flow Reserve
Versus Angiography for Multivessel Evalua-
tion) trial data (5,6), some clinicians remain
skeptical of the value of PCI in the context
of stable coronary artery disease (7), which
reduces enthusiasm for invasive FFR
assessment.
VIRTUAL FFR
There is, therefore, a need for a method that
delivers the beneﬁts of physiological lesion
assessment to every cardiologist without
the practical drawbacks that limit the inva-
sive technique. Several groups have used
computational ﬂuid dynamics (CFD) alliedto anatomical models based upon coronary imaging to
compute FFR without passage of a pressure wire. This
is becoming known as virtual fractional ﬂow reserve
(vFFR) or computed FFR.
COMPUTATIONAL FLUID DYNAMICS
CFD is a branch of ﬂuid mechanics and a specialist
area of mathematics that uses numerical methods and
computer algorithms to simulate and analyze ﬂuid
ﬂow. CFD modeling is a highly accurate method that is
relied upon in a wide range of safety-critical industrial
applications, such as aircraft design. Almost all CFD
analyses are based upon solving the Navier Stokes and
conservation equations: the governing equations of
ﬂuid ﬂow, which represent Newton’s second law
(balance of momentum) and conservation of mass,
respectively, in a continuums approach. CFD models
of vFFR require anatomical and physiological inputs.
Arterial anatomy is “segmented” from coronary im-
aging (computed tomography [CT] or invasive angi-
ography) and reconstructed into 2- or 3-dimensional
(3D) in silico surface representations. These arterial
models must then be discretized, or “meshed,” into a
ﬁnite number of volumetric elements. In addition, the
time-step of the simulation must be deﬁned. The
processes of spatial and temporal “discretization”
determines the ﬁdelity and reﬁnement of a given
analysis. The physical conditions at the inlet, out-
let(s), and arterial walls must then be deﬁned (i.e., the
“boundary conditions”). A computer ﬁle that fully
deﬁnes the spatial, temporal, and physiological
bounds of the modeled system is then generated andexecuted using specialist software known as a CFD
“solver,” which simulates the distribution and dy-
namics of blood pressure, ﬂow, and shear stress
within the artery over time. These data are used to
generate predictions regarding pressure and ﬂow
changes across coronary stenoses, from which vFFR
can be calculated at any point along the vessel. These
processes and the key stages of developing a typical
vFFR workﬂow are demonstrated in Figure 1.
Theoretically, computing the pressure drop across
a stenosis is an elementary CFD problem. However,
due to practical and clinical limitations, the geometric
and hemodynamic factors that inﬂuence blood ﬂow
and energy loss along a diseased coronary artery are
complex.
vFFR DERIVED FROM COMPUTED
TOMOGRAPHIC CORONARY ANGIOGRAPHY
vFFR derived from computed tomographic coronary
angiography (CTCA) (vFFRCT) has accumulated the
most signiﬁcant evidence base to date. DISCOVER-
FLOW (Diagnosis of Ischemia-Causing Stenoses Ob-
tained Via Noninvasive FFR) was the ﬁrst major
published trial of vFFRCT (Table 1) (8). With measured
FFR as the reference standard, this study of 103 pa-
tients (159 vessels) demonstrated how CTCA-derived
vFFR added value to standard CTCA in reducing
the number of false positive results. On a per-patient
(cf., per-vessel) basis, vFFRCT diagnosed physiolog-
ical lesion signiﬁcance (FFR >0.80 or #0.80) with
87.4% (95% conﬁdence interval [CI]: 79% to 93%)
overall accuracy. This was signiﬁcantly superior to
standard CTCA (61%; 95% CI: 51% to 71%). The results
of the larger follow-up DEFACTO (Determination
of Fractional Flow Reserve by Anatomic Computed
Tomographic AngiOgraphy) trial (per-patient diag-
nostic accuracy 73%; 95% CI: 67% to 78%), however,
did not meet the author’s pre-deﬁned outcome goal
in terms of per-patient diagnostic accuracy (9). The
more recent HeartFlow NXT (HeartFlow Analysis of
Coronary Blood Flow Using CT Angiography: Next
Steps) trial further assessed vFFRCT, utilizing “upda-
ted proprietary software,” “improved segmentation,”
“reﬁned physiological models,” and “increased
automation,” which generated improved diagnostic
accuracy in a larger cohort of 251 patients (484 ves-
sels) (per-patient accuracy 81% (95% CI: 76% to 85%)
(10). Subsequently, HeartFlow, Inc. has gained U.S.
Food and Drug Administration (FDA) approval for
the use of vFFRCT as a class II Coronary Physiologic
Simulation Software Device (11). vFFRCT is computed
using standard CTCA protocols without induction of
hyperemia and is, therefore, a highly practical and
FIGURE 1 A vFFR Model Workﬂow
Coronary angiogram (A) is “segmented” and reconstructed (B) into a 3-dimensional (3D) model (C). Surface and volumetric meshing “discretize” the patient-speciﬁc
geometry (C). The physiological conditions beyond the modeled section must be represented at each boundary, that is, “boundary conditions” (D). Computational ﬂuid
dynamics simulation computes the pressure gradient, using the anatomical 3D model “tuned” with physiological parameters. Pressure ratio is computed from output data
(E). Results are validated against invasive measurements during development (F). vFFR ¼ virtual fractional ﬂow reserve.
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1011useful method in outpatients, which may reduce the
number of unnecessary referrals for invasive angiog-
raphy. However, only dichotomized data have been
reported thus far. Data regarding the agreeability
between vFFR and measured values were not pub-
lished in the aforementioned trials. The vFFRCT
method assumes a predictable response to adenosine,
which is controversial (12). Furthermore, vFFRCT is
limited by the same factors that limit standard CTCA,
namely calciﬁcation, tachycardia, and arrhythmia.
Although the latest technological developments used
in the NXT trial clearly improved accuracy in this
cohort, a precise description of the methods and al-
gorithms have not been published, which precludes
further scrutiny.
vFFR FROM INVASIVE ANGIOGRAPHY
All patients considered for revascularization un-
dergo invasive coronary angiography (CAG), which
remains the gold standard method for diagnosingand assessing coronary artery disease. Several
groups have, therefore, attempted to model vFFR
based upon CAG imaging (vFFRCAG). In the VIRTU-1
(VIRTUal Fractional Flow Reserve From Coronary
Angiography) study, Morris et al. (13) constructed a
computational workﬂow that computed vFFR from
CAG images. In 35 diseased vessels, the VIRTU-
HEART model (University of Shefﬁeld, Shefﬁeld,
United Kingdom) predicted (dichotomized) physio-
logical lesion signiﬁcance with 97% accuracy, albeit
with a paucity of FFR cases within the critical 0.75
to 0.85 range. Average error between vFFR and
measured FFR was 0.06.
Tu et al. (14) developed a model based upon 3D
quantitative coronary angiography (QCA) and the
much faster steady-ﬂow CFD analysis (cf., transient,
see the following text), with mean hyperemic ﬂow
velocity derived from Thrombolysis In Myocardial
Infarction (TIMI) frame counting. Unlike the afore-
mentioned models, this model requires induction of
hyperemia (a potential factor contributing to current
TABLE 1 Summary of Methodology and Precision of Models of vFFR
vFFR
Model/Study
(Ref. #)
Patients,
Vessels (n)
Imaging
Modality
CFD
Simulation
Boundary
Condition
Strategy Other
Versus Invasively
Measured FFR
Approximate
Run Time
Overall
Diagnostic
Accuracy*
Area Under
ROC Curve* Agreeability
Pearson
Correlation
Coefﬁcient
Bias
(Mean  SD)
CTCA-FFR (16)
DISCOVER-FLOW (8)
103, 159 CTCA 3D CFD On the basis of
vessel diameter
and myocardial
mass
Coupled lumped
parameter model at
outlets (HeartFlow
software
version 1.0)
84%
(per-vessel)
0.90 Not reported
quantitatively;
see Bland-Altman
plot in
original
publication
0.68
(p < 0.0001)
0.02  0.116 Remote core
laboratory
computation
CTCA-FFR
DeFACTO (9)
252, 407 CTCA 3D CFD On the basis of
vessel diameter
and myocardial
mass
Coupled lumped
parameter model at
outlets (HeartFlow
software
version 1.2)
69%
(per-vessel)
0.81 (per-patient,
per-vessel not
reported)
Not reported
quantitatively
0.63 0.06
(SD not reported)
Remote core
laboratory
computation
VIRTU-1 (13) 20, 35 CAG Transient 3D Pressure Coupled lumped
parameter model
at outlets
97%
(per-vessel)
0.97 vFFR deviated from
mFFR by 
0.06 (mean
error) (Plus see
Bland-Altman
plot in original
publication)
0.84 0.02  0.080 12–24 h
vFAI (17) 120, 139 CAG Steady-state 3D Flow Derived from
DP-ﬂow curve
87.8% 0.92 Not applicable† 0.78 0.00  0.085 7 min
CTCA-FFR
HeartFlow NXT (10)
251, 484 CTCA 3D CFD On the basis of
vessel diameter
and myocardial
mass
Coupled lumped
parameter model at
outlets (HeartFlow
software
version 1.4)
86%
(per-vessel)
0.93
(per vessel)
Not reported
quantitatively;
see Bland-Altman
plot in original
publication
0.82 0.02  0.074 Remote core
laboratory
computation
FFRQCA (14) 68, 77 CAG Steady-state 3D Mean ﬂow (derived
from TIMI
frame count)
88.3% 0.93 Not reported
quantitatively;
see Bland-Altman
plot in original
publication
0.81 0.00  0.06 5 min
Data derived on the basis of our best interpretation of the published data. *Diagnostic accuracy in diagnosing physiological lesion signiﬁcance of an invasively measured FFR of <0.80 or >0.80. †vFAI is a surrogate marker of functional lesion assessment.
3D ¼ 3-dimensional; CAG ¼ invasive coronary angiography; CFD ¼ computational ﬂuid dynamics; CTCA ¼ computed tomographic coronary angiography; DeFACTO ¼ Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiOgraphy;
DISCOVER-FLOW ¼ Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive FFR; FFR ¼ fractional ﬂow reserve; mFFR ¼ invasively measured fractional ﬂow reserve; HeartFlow NXT ¼ HeartFlow Analysis of Coronary Blood Flow Using CT Angiography: Next
Steps; QCA ¼ quantitative coronary angiography; ROC ¼ receiver-operating characteristic; TIMI ¼ Thrombolysis In Myocardial Infarction; vFAI ¼ virtual functional assessment index; vFFR ¼ virtual fractional ﬂow reserve; VIRTU-1 ¼ VIRTUal Fractional Flow Reserve
From Coronary Angiography.
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FIGURE 2 vFFR Virtual Pullback Result
Pressure distribution throughout a right coronary artery (RCA) allowing individual lesion
evaluation. vCFR ¼ virtual coronary ﬂow reserve; vFFR = virtual fractional ﬂow reserve.
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1013FFR underuse) during CAG. Nevertheless, their model
provided diagnostic accuracy of 88.3% in 77 cases.
Papafaklis et al. (15) developed a model predicting
“virtual functional assessment index (vFAI) for
fast functional assessment of intermediate coronary
lesions.” This model does not compute vFFR. Instead,
this model uses 3D QCA and steady-ﬂow CFD analysis
to compute the ratio of distal to proximal pressure
over the lesion for ﬂows in the range 0 to 4 ml/s,
normalized by the ratio over this range for a normal
artery. The pressure ratio as a function of ﬂow is
described as a quadratic equation, with coefﬁcients
determined by steady-state CFD analysis at 2 ﬂow
rates (1 and 3 ml/s). vFAI is numerically equal to the
average of the computed pressure ratio over this
ﬂow range. This approach is fast, but it ignores the
critical physiological inﬂuence of the coronary micro-
vascular resistance (see the following text). In their
trial of 139 vessels (n ¼ 120), vFAI was superior to
standard 3D QCA in predicting physiological lesion
signiﬁcance; a vFAI cut-off of #0.82 was associated
with overall diagnostic accuracy of 88%.
ADVANTAGES OF vFFR
Early vFFR results using CT (16) and angiographic
images (13,14) are encouraging, and in the case of
CTCA vFFR, have reached clinical applicability.
Beyond simply replacing invasive FFR and providing
the beneﬁts of physiological assessment in the many
patients not currently afforded them, vFFR offers
some additional advantages. vFFR provides a virtual
pullback, in which pressure is demonstrated at all
points within a branched coronary arterial tree in a
single analysis, allowing the physiological signiﬁ-
cance of serial lesions to be evaluated accurately and
individually, a process far more challenging with
invasive FFR (Figure 2). It can also provide a “virtual
stenting” facility, whereby the physiological effect of
alternative interventional strategies can be trialed in
silico (by computer simulation) before treatment is
delivered in vivo. vFFR can also assess any segment
of the coronary tree, including those to which it might
be challenging to pass a pressure wire.
CHALLENGES
Several scientiﬁc, logistic, and commercial challenges
must be overcome, however, before vFFR can enter
routine clinical use.
SEGMENTATION
Segmentation from medical images, whether they be
derived from CTCA or CAG, is crucial to the accuracyof CFD simulation. CT-based vFFR is apposite for
truly noninvasive vFFR, but CTCA is mainly used
to rule out coronary artery disease in those with
low-to-medium pre-test probability of coronary ar-
tery disease, rather than for detailed planning of
revascularization. In many patients, CTCA does not
provide sufﬁcient image quality for accurate seg-
mentation, whether due to cardiac or respiratory
movement, tachycardia or arrhythmia leading to a
“stair-step” artefact, phase misregistration or blur-
ring, or calciﬁcation leading to “blooming” or
“streaking” (17). The noninvasive nature of CTCA also
prevents the measurement of other physiological
parameters that can be used to inform CFD simula-
tion. Segmentation from CAG is also challenging.
Current protocols most commonly segment from just
2 projections, which may under-represent the full
3D anatomy. Software is used to correct for patient
movement between acquisitions, but this is not
entirely robust, and biplane CAG acquisition is not
available in the majority of catheter laboratories.
Rotational coronary angiography can be successful
because it offers the potential to use multiple views in
the reconstruction, or at least the option to select 2
optimal projections, eliminating vessel overlap, fore-
shortening, and inadequate opaciﬁcation, but is also
not widely available. Methods such as intravascular
ultrasound and (particularly) optical coherence to-
mography would add detailed anatomical accuracy,
FIGURE 3 Electric
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1014but problems of image co-registration, the techniques’
invasiveness, and increased cost on top of the CTCA
and CAG imaging, make them impractical in the
context of vFFR.BOUNDARY CONDITIONS
The physical conditions affecting each of the bound-
aries (inlets, outlets, and vessel walls) must be
accurately represented in the model. Identifying a
noninvasive strategy for tuning (or “parameterizing”)
these boundary conditions probably presents the
greatest challenge. For the purpose of computing
vFFR, there is no strong evidence that it is necessary
to represent the motion or compliance of the vessel
wall. The inlet pressure is relatively easy to deter-
mine, either from direct measurement of aortic
pressure in a CAG-based model, or from cuff-pressure
with a transfer function in the case of CTCA.
The distal outlet boundary conditions are difﬁcult
to determine because they are those of the coronary
microvasculature circulation (CMVC) that are het-
erogeneous in health and disease and require direct
invasive measurement, which we wish to avoid in
minimally invasive modeling. Figure 3 demonstrates
why the accuracy of vFFR computation is absolutely
dependent upon the CMVC.
This is relevant when considering the vFAI, which
is entirely a function of stenosis geometry andal Model Demonstrating the Importance of the Distal Boundary
tation
nd resistance (R) are analogous to electrical potential difference,
ce. Rstenosis and coronary microvasculature circulation resistance
ly 2 resistors arranged in series. Therefore, even if Paorta and Rstenosis
uted), computation of virtual fractional ﬂow reserve (vFFR) is wholly
rameters of RCMVC, because this determines Pdistal and, hence, vFFR. If
verestimated, lesion severity and the potential beneﬁt from revas-
restimated, that is, vFFR > fractional ﬂow reserve, and vice versa.ignores the inﬂuence of the CMVC (15). Although
likely to be superior to QCA alone (because the geo-
metric description is transformed into a more physi-
ologically relevant measure, namely pressure ratio),
vFAI cannot be a substitute for FFR, because unlike
FFR, it ignores the CMVC. The vFAI will always be
low, indicating the need for intervention, if the lesion
is geometrically signiﬁcant, whereas the FFR might
be high or low for the same lesion depending on the
overall physiology, and in particular on the status of
the coronary microvasculature. Although on average
there is expected to be a correlation between vFAI
and FFR (because the pressure ratio is likely to be
lower when the lesion is more geometrically signiﬁ-
cant), differences would occur whenever the imped-
ance of the microvasculature deviates signiﬁcantly
from normal, and these are exactly the circumstances
that are captured by FFR.
Morris et al. (13) and Taylor et al. (17) both apply a
lower-order model to represent the distal (outlet)
boundaries (Figure 4). Morris et al. (13) employed a
generic, average, “one-size-ﬁts-all” approach to
parameterization. Although this model generated
impressive overall accuracy, individual patient ac-
curacy was improved signiﬁcantly (the error was
halved) by applying invasively measured parameters
of CVMC (13). Taylor et al. (17) implement a strategy
based upon ventricular wall volume (from CT imag-
ing), brachial blood pressure, and a morphometric law
that deﬁnes the relationship among resistance, ﬂow,
and vessel diameter. Although this is a more
sophisticated strategy, hyperemic CMVC resistance is
similarly derived from averaged, population-based
data. Ultimately, both models are prone to errors
secondary to variability in hyperemic CMVC resis-
tance (Figure 3).
Applying ﬂow as a boundary condition is a sensible
alternative, because this accounts for CMVC resis-
tance. However, measurement of absolute hyperemic
coronary ﬂow is invasive, challenging, and requires
induction of hyperemia. Estimating mean ﬂow rate
from TIMI frame count yields respectable results that
correlate to Doppler wire analysis, but this is only
apposite for steady-ﬂow analysis and cannot easily be
applied to a transient CFD analysis (see the following
text) (14).
If vFFR is to succeed, a strategy that provides
personalized estimation of the distal boundary con-
ditions, using noninvasive clinical data, is required.
CFD SIMULATION
The optimal method of CFD simulation is also yet
to be determined. The coronary circulation is a
FIGURE 4 Modeling the distal coronary boundary
The 3-dimensional (3D) coronary model is coupled to a 0-dimensional, lumped parameter
model to represent the physiological conditions at the distal boundary (right). An elec-
trically analogous Windkessel design represents the impedance (Z), resistance (R), and
capacitance (C) of the distal coronary microvasculature circulation. The algebraically coded
Windkessel computes pressure (P) and ﬂow (Q), which dynamically informs the 3D
computational ﬂuid dynamics simulation. As in Figure 3, model parameters are vital to
patient-speciﬁc accuracy.
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S V O L . 8 , N O . 8 , 2 0 1 5 Morris et al.
J U L Y 2 0 1 5 : 1 0 0 9 – 1 7 ”Virtual” (Computed) FFR
1015dynamic, 3D, pulsatile system; transient (timed
dependent) 3D CFD simulation is, therefore, con-
sidered the most representative and accurate
method. This involves solving for millions of de-
grees of freedom (the possible independent varia-
tions in a dynamic system within the constraints
imposed upon it) of a nonlinear, partial differential
equation simultaneously and repeatedly, hundreds
or thousands of times each cardiac cycle. This is
computationally time-consuming (approximately 12
to 24 h), notwithstanding the steady increase in
computational speed. Modelers have sought quicker
alternatives.
Steady-state CFD analysis can be used rather than
transient. This runs more quickly (2 min) but does not
represent the accelerative, time-dependent behavior
of pulsatile blood ﬂow. However, this has been
demonstrated to yield respectable vFFR accuracy
(14). Reduced order (1-dimensional) CFD simulation is
also fast, but does not represent the 3D nature of the
coronary tree. Although steady ﬂow analyses have
simulated similar ﬂow and shear stress patterns (18),
the trade-off between simplifying computation and
effect on accuracy needs to be fully evaluated.
COMPUTATION TIME
Prolonged vFFR computation times, over many
hours, have been a major concern and may limit
vFFR applicability. This is less crucial for CT-FFR,
but is more important for CAG-related methods
where real-time, on-table results are required. Off-
line, remote, supercomputer simulation represents
one solution, but this is less attractive than system
acceleration that allows real-time processing within
software integrated into local catheter-laboratory
systems. The adoption of very high-powered
computation locally is not easily accommodated
within parsimonious health care systems. Steady-
state or reduced-order modeling are further op-
tions, with CFD results being generated within 5 min,
which is comparable to invasive measurement (14).
Unlike invasive FFR, vFFR can also evaluate several
coronaries and lesions in a single analysis. Using
steady-state or 1-dimensional modeling is attractive
but may sacriﬁce accuracy. However, the challenge
of system acceleration appears eminently achievable.
MODEL COMPLEXITY AND DESIGN
Complex models, requiring invasive measurements
with prolonged run times, have improved accuracy,
but physicians require simple, rapid systems of
sufﬁcient accuracy to inform treatment decisions.Further work is needed to discern models that bal-
ance these needs optimally. One potential solution
is a multitiered approach that delivers fast results
but with wide conﬁdence margins, reserving more
complex modeling for more borderline cases where
increased precision is required. Furthermore, is there
an appetite for remote supercomputation (raising
issues of transferring large conﬁdential datasets
outside of the hospital), or would physicians prefer
to run analyses themselves using systems within
their catheterization laboratory?
ACCURACY AND VALIDATION
Accuracy is absolutely key to vFFR’s success. How-
ever, what constitutes accuracy is yet to be deﬁned.
Perhaps most important is whether vFFR correctly
assigns a patient to treatment to produce alleviation
of symptoms. Currently, this accords with a treatment
threshold of FFR <0.80. A related measure of accu-
racy is how close vFFR values approximate the
measured values over the whole range, and if so, how
close is acceptable? Because FFR itself varies between
repeat measurements (19), the comparative accuracy
of vFFR is also restricted. Furthermore, should ac-
curacy be deﬁned on a per-patient or per-vessel basis?
A Bland-Altman plot is the best statistical metric
for evaluating vFFR accuracy against FFR, but this
method does not lend itself to making comparison
between different models. Although often quoted,
correlation coefﬁcients are misleading and do not
reﬂect agreeability. Ultimately, demonstrating clin-
ical success is vital, regardless of agreement with
other methods, and prospective, randomized con-
trolled trials will be necessary. If computed clinical
results are to be truly believed and used in making
clinical decisions, then, in addition to comparing
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1016computed and measured results, authors should
describe their numerical methodology and demon-
strate validation of their algorithms. Although CFD
software packages can be used by the nonexpert,
considerable multidisciplinary experience is required
to generate robust and reliable data. Successful vali-
dation requires clinical, mathematical, biomechanical
engineering, and modeling expertise.
COMMERCIAL CONSIDERATIONS
Around 1 million PCI procedures are performed annu-
ally in the United States at a cost of approximately
$10 billion; the rewards for successfully modeling
vFFR are therefore considerable. Understandably,
academics, funders, and investors are keen to pro-
tect their intellectual and ﬁnancial investment and
to prevent their own work being restricted by
another group or interested party. CFD is a mature
technology with a signiﬁcant base of published
data (“prior art”), but there are several patentable
aspects of the analysis process, and a number of
patents have already been granted.
In the context of interventional cardiology, CFD
modeling is a new technology that is potentially
disruptive, especially to manufacturers of hardware
that may become redundant if vFFR is successful.
Traditionally-minded manufacturers and physicians
will need to embrace these new techniques and
engage with academics and modelers to ensure that
the best methods are adopted.
Medicare reimbursement has boosted FFR use in
the United States. Now that CTCA-based vFFR has
been approved by the FDA, a similar arrangement
is needed.
There are currently no industry standards re-
garding accuracy, reliability, or validation. The FDA
is addressing this through a benchmarking initia-
tive that aims to advance the application of CFD
technology within the regulatory context (20). A
consistent, evidence-based strategy administered by
experts is also needed in Europe.TRIAL EVIDENCE AND
CLINICAL CONSIDERATIONS
Most physicians are unaware of the basic principles,
strengths, and weaknesses of CFD modeling and,
hence, vFFR. Academics, modelers, and engineers
should engage with the clinical community in an open
and transparent manner with regard to the merits and
limitations of computational modeling. vFFR systems
must be simple and intuitive to maximize adoption
and for safe use by physicians who are not CFD ex-
perts. Prior to clinical acceptance, 2 imperatives must
be met. The ﬁrst is to demonstrate equivalence of
vFFR to invasive FFR in clinical practice in situations
when FFR is currently used. The second is to compare
vFFR tools within traditional decision pathways at
the stage of diagnostic angiography (CAG or CTCA) for
the many thousands of patients who are not currently
offered physiological assessment.
CONCLUSIONS
A number of scientiﬁc, logistical, political, and com-
mercial challenges must be overcome before vFFR
enters routine clinical practice. Issues regarding
model personalization, image segmentation, and
boundary condition tuning are particularly impor-
tant. These challenges are not insurmountable; early
results are encouraging despite current limitations.
Assuming successful development continues in these
key areas, vFFR is likely to become a desirable tool in
the functional assessment of coronary artery disease.
CT derived vFFR is emerging as a useful tool for low
/medium risk patients whereas more invasive vFFR
applications are emerging as useful tools in higher
risk patients undergoing invasive management.
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